Friulimicin B
- Generic Name
- Friulimicin B
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C59H94N14O19
- CAS Number
- 239802-15-4
- Unique Ingredient Identifier
- AYO43961I1
- Background
Friulimicin B is a naturally occurring antibiotic produced by a micro-organism, Actinoplanes friuliensis. It shows strong cidal activity against a number of Gram-positive pathogens which commonly cause serious infections in hospital patients and which are becoming more routinely acquired in the community.
- Indication
Investigated for use/treatment in bacterial infection.
- Associated Conditions
- -
- Associated Therapies
- -
First Time in Man Trial for Friulimicin B
Phase 1
Terminated
- Conditions
- Interventions
- First Posted Date
- 2007-06-27
- Last Posted Date
- 2008-07-23
- Lead Sponsor
- MerLion Pharmaceuticals GmbH
- Target Recruit Count
- 31
- Registration Number
- NCT00492271
- Locations
- 🇨ðŸ‡
Swiss Pharma Contract Ltd, Basel, Switzerland
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath